More EMvision Medical Devices Ltd. news
EMvision Medical Devices Ltd.ASX: EMV

S&P DJI Announces March 2025 Quarterly Rebalance

Mar 7, 2025 at 6:22 AM EST · Issued by EMvision Medical Devices Ltd.

Filed with ASX · Mar 7, 2025 at 6:22 AM EST · 8 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2025-quarterly-rebalance-83

EMvision Medical Devices Ltd. on 6ix

Earlier from EMvision Medical Devices

  • EMVision Releases its FY25 Half Yearly ReportFeb 27, 2025
  • US Ethics Approval Received for Pivotal Validation TrialFeb 11, 2025
  • EMVision Receives $2.12m R&D Tax RebateJan 19, 2025
  • Algorithms Deliver Excellent Results In EMView StudyNov 11, 2024
  • EMV Prepares for Trial Following Positive FDA EngagementOct 28, 2024

Later from EMvision Medical Devices

  • First Responder Scanner in Successful Aeromedical TestingMar 18, 2025
  • Emu Pivotal Validation Trial CommencesMar 26, 2025
  • Activation of Second US Pivotal Trial Site, Mayo ClinicApr 27, 2025
  • Enhanced Algorithm Performance From Continuous InnovationMay 20, 2025
  • Additional Pivotal Trial Site ActivationsJun 2, 2025
All EMvision Medical Devices news releases↗

Follow EMvision Medical Devices into a list and get an email when it puts out news.

Follow EMvision Medical Devices
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer